"A Phase III, Multicenter, Randomized, Open-Lable Clinical Trial Comparing the Efficacy and Safety of MK-0431 A (the Fixed-Dose Combination of Sitagliptin and Metformin) to That of Liraglutide in Patients With Type 2 Diabetes Mellitus"

drug protocol number
MK-0431A-180-00
drug sponsor
MSD
drug study
MK-0431A (Sitagliptin / Metformin) vs Liraglutide
drug trial site
King Khalid University Hospital (Riyadh)
drug status
Terminated
drug phase